I thank the gentleman for yielding. I would also like to thank my colleague, Mr. Griffith, for all his work on this very important legislation. I would also like to thank him for including language that requires a report on the impact of PDMPs on patient access to appropriate care. This is critical for epilepsy patients that can face barriers to accessing their Schedule V non- narcotic drugs necessary to control their seizures. Several epilepsy medications are classified as Schedule V and, therefore, fall under monitoring requirements, despite the fact that they are non-opioid, non-narcotic, and there is no evidence to indicate that these medications are being abused by people with epilepsy. This has led to unnecessary delays in access to their prescribed therapy. A handful of States have passed legislation that removes non-narcotic drugs from reporting requirements. As we work through legislation intended to combat the opioid crisis, we need to ensure that we do not limit access to legitimate care, especially to non-narcotic drugs.
Share
More from John Rice Carter
I thank the gentleman for yielding. Mr. Speaker, I rise today in support of H.R. 3293, the Expediting Federal Broadband Deployment Reviews Act. I thank the bipartisan sponsors for this bill in working to close the digital divide. There are…
EVs have a future in our transportation system. If you want to buy an EV, that is your choice. We will happily sell you one from the State of Georgia, but I don't think government should corner Americans into buying a car based on…
I thank the gentleman for yielding. Mr. Speaker, I rise today in support of H.R. 7224, which reauthorizes the Stop, Observe, Ask, and Respond to Health and Wellness Act. I am proud to co-lead this important bill with the gentleman from…
The Department of Commerce's mission to spur economic growth and opportunities for all Americans grows more and more important every day.





